Chemoinformaics analysis of (-)-Dehydrodicatechin A
| Molecular Weight | 576.51 | nRot | 1 |
| Heavy Atom Molecular Weight | 552.318 | nRig | 41 |
| Exact Molecular Weight | 576.127 | nRing | 8 |
| Solubility: LogS | -4.301 | nHRing | 4 |
| Solubility: LogP | 2.295 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 3 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 18 |
| nHA | 12 | APOL | 75.727 |
| nHD | 7 | BPOL | 31.889 |
| QED | 0.208 |
| Synth | 6.239 |
| Natural Product Likeliness | 2.268 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.055 |
| Pgp-sub | 0.002 |
| HIA | 0.873 |
| CACO-2 | -6.406 |
| MDCK | 0.00000588 |
| BBB | 0.012 |
| PPB | 0.931884 |
| VDSS | 0.482 |
| FU | 0.0630567 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.881 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.319 |
| CYP2c9-sub | 0.436 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.219 |
| CYP3a4-inh | 0.359 |
| CYP3a4-sub | 0.762 |
| CL | 16.479 |
| T12 | 0.445 |
| hERG | 0.059 |
| Ames | 0.459 |
| ROA | 0.901 |
| SkinSen | 0.961 |
| Carcinogencity | 0.251 |
| EI | 0.772 |
| Respiratory | 0.034 |
| NR-Aromatase | 0.786 |
| Antiviral | Yes |
| Prediction | 0.798867 |